| Table VI.I: The Number of States Reporting Having Communication or Interactions with Pharmacy Regulatory Bodies in Other States Related to Drug Compounding Issues | |||
|---|---|---|---|
| Number of states (%) | |||
| Yes | No | Don't know | No response |
| 42 (84) | 5 (10) | 2 (4) | 1 (2) |
| Source: GAO survey of state pharmacy regulatory bodies, survey question 39. | GAO-17-363SP |
| Note: GAO surveyed the state pharmacy regulatory bodies in the 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands, and all but 4 completed the survey. |